Acro Biomedical (ACBM) Asset Utilization Ratio (2018 - 2023)

Acro Biomedical has reported Asset Utilization Ratio for 6 years, with the latest figure at 1.29 in Q3 2023.

• On a quarterly basis, Asset Utilization Ratio fell 5.54% year-over-year to 1.29 in Q3 2023; TTM through Sep 2023 was 1.29, a 5.54% decrease from a year earlier, with the FY2022 full-year figure at 0.91, down 33.22% from the prior year.
• Asset Utilization Ratio was 1.29 for Q3 2023 at Acro Biomedical, up from 0.6 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 4.94 in Q1 2019, with the low at 0.54 in Q1 2023.
• Average Asset Utilization Ratio over 5 years is 1.45, with a median of 0.99 recorded in 2022.
• The sharpest annual moves came in 2020 and 2022: Asset Utilization Ratio tumbled 81.73% in 2020, then surged 130.59% in 2022.
• Over 5 years, Asset Utilization Ratio stood at 1.55 in 2019, then sank by 42.63% to 0.89 in 2020, then soared by 94.11% to 1.72 in 2021, then slumped by 42.54% to 0.99 in 2022, then soared by 30.38% to 1.29 in 2023.
• The last three Asset Utilization Ratio figures came in at 1.29 (Q3 2023), 0.6 (Q2 2023), and 0.54 (Q1 2023), per Business Quant data.